Alnylam: Upcoming FDA Meeting Could Create Some Volatility (NASDAQ:ALNY)

Blood pressure monitor tube in the shape of Lung. Hypertension on concept. 3d illustration.

Surendra Sharma/iStock via Getty Images

I can’t complain too much about the performance of Alnylam Pharmaceuticals (NASDAQ:ALNY) operationally or in stock market terms since my last update on this biotech. The company has continued to deliver positive data

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *